Literature DB >> 19923901

Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates.

Karin Almstedt1, Sofie Nyström, K Peter R Nilsson, Per Hammarström.   

Abstract

Propagation and infectivity of prions in human prionopathies are likely associated with conversion of the mainly alpha-helical human prion protein, HuPrP, into an aggregated form with amyloid-like properties. Previous reports on efficient conversion of recombinant HuPrP have used mild to harsh denaturing conditions to generate amyloid fibrils in vitro. Herein we report on the in vitro conversion of four forms of truncated HuPrP (sequences 90-231 and 121-231 with and without an N-terminal hexa histidine tag) into amyloid-like fibrils within a few hours by using a protocol (phosphate buffered saline solutions at neutral pH with intense agitation) close to physiological conditions. The conversion process monitored by thioflavin T, ThT, revealed a three stage process with lag, growth and equilibrium phases. Seeding with preformed fibrils shortened the lag phase demonstrating the classic nucleated polymerization mechanism for the reaction. Interestingly, comparing thioflavin T kinetics with solubility and turbidity kinetics it was found that the protein initially formed nonthioflavionophilic, morphologically disordered aggregates that over time matured into amyloid fibrils. By transmission electron microscopy and by fluorescence microscopy of aggregates stained with luminescent conjugated polythiophenes (LCPs); we demonstrated that HuPrP undergoes a conformational conversion where spun and woven fibrils protruded from morphologically disordered aggregates. The initial aggregation functioned as a kinetic trap that decelerated nucleation into a fibrillation competent nucleus, but at the same time without aggregation there was no onset of amyloid fibril formation. The agitation, which was necessary for fibril formation to be induced, transiently exposes the protein to the air-water interface suggests a hitherto largely unexplored denaturing environment for prion conversion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923901      PMCID: PMC2807696          DOI: 10.4161/pri.3.4.10112

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  30 in total

1.  Crystal structure of the human prion protein reveals a mechanism for oligomerization.

Authors:  K J Knaus; M Morillas; W Swietnicki; M Malone; W K Surewicz; V C Yee
Journal:  Nat Struct Biol       Date:  2001-09

2.  Pathway complexity of prion protein assembly into amyloid.

Authors:  Ilia V Baskakov; Giuseppe Legname; Michael A Baldwin; Stanley B Prusiner; Fred E Cohen
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

Review 3.  Regulation and modulation of pH in the brain.

Authors:  Mitchell Chesler
Journal:  Physiol Rev       Date:  2003-10       Impact factor: 37.312

4.  NMR solution structure of the human prion protein.

Authors:  R Zahn; A Liu; T Lührs; R Riek; C von Schroetter; F López García; M Billeter; L Calzolai; G Wider; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  The preparation of guanidine hydrochloride.

Authors:  Y Nozaki
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

6.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

7.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

8.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

9.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

10.  The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site.

Authors:  Ralph Zahn
Journal:  J Mol Biol       Date:  2003-11-28       Impact factor: 5.469

View more
  13 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

3.  True and apparent inhibition of amyloid fibril formation.

Authors:  Pedro M Martins
Journal:  Prion       Date:  2012-12-11       Impact factor: 3.931

4.  Human beta-synuclein rendered fibrillogenic by designed mutations.

Authors:  Shahin Zibaee; Graham Fraser; Ross Jakes; David Owen; Louise C Serpell; R Anthony Crowther; Michel Goedert
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

5.  Two amyloid States of the prion protein display significantly different folding patterns.

Authors:  Valeriy G Ostapchenko; Michael R Sawaya; Natallia Makarava; Regina Savtchenko; K Peter R Nilsson; David Eisenberg; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2010-05-27       Impact factor: 5.469

6.  Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation.

Authors:  Nicolas L Fawzi; Jinfa Ying; Dennis A Torchia; G Marius Clore
Journal:  J Am Chem Soc       Date:  2010-07-28       Impact factor: 15.419

7.  Purification and fibrillation of full-length recombinant PrP.

Authors:  Natallia Makarava; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2012

8.  Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates.

Authors:  Ilan Margalith; Carlo Suter; Boris Ballmer; Petra Schwarz; Cinzia Tiberi; Tiziana Sonati; Jeppe Falsig; Sofie Nyström; Per Hammarström; Andreas Aslund; K Peter R Nilsson; Alice Yam; Eric Whitters; Simone Hornemann; Adriano Aguzzi
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

9.  Prion protein-coated magnetic beads: synthesis, characterization and development of a new ligands screening method.

Authors:  Marcela Cristina de Moraes; Juliana Bosco Santos; Daniel Meira Dos Anjos; Luciana Pereira Rangel; Tuane Cristine Ramos Gonçalves Vieira; Ruin Moaddel; Jerson Lima da Silva
Journal:  J Chromatogr A       Date:  2014-12-12       Impact factor: 4.759

10.  Purification and Fibrillation of Full-Length Recombinant PrP.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.